TNF-α triggers the disruption of tumor vasculature, reduces intra-tumoral interstitial fluid pressure (IFP) and promotes the flow of blood to tumors, and TNF-α is used to improve drug delivery to tumors (45). This evidence concerns the gene TNF and neoplasm.